Results 71 to 80 of about 2,233 (157)

Tezepelumab in Adults with Uncontrolled Asthma

New England Journal of Medicine, 2019
openaire   +2 more sources

Tezepelumab in severe asthma with pulmonary mucus plugs and eosinophilic chronic rhinosinusitis after dupilumab intolerance and suboptimal mepolizumab response: A case report. [PDF]

Respir Med Case Rep
Senoo S, Fukushima K, Takata K, Matsumori S, Baba T, Sugisaki Y, Omori H, Matsuura H, Taniguchi A, Omote R, Miyahara N, Okada T.   +11 more
europepmc   +1 more source

Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain. [PDF]

Pharmacoecon Open
Villamañan E, Quirce S, Torres C, Martínez N, Garí C, Vidal-Vilar N, Almonacid C.   +6 more
europepmc   +1 more source

Reply to: Malik MMUD on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT). [PDF]

Int Forum Allergy Rhinol
Mullol J, Han JK, Laidlaw TM, Hopkins C, Peters AT, Pfaar O, Desrosiers M, Lee SE, Lane AP, Chen C, Chon Y, Ponnarambil SS, Foster A, Lindsley AW, Ambrose CS.   +14 more
europepmc   +1 more source

Biologic Use in Type 2 versus Non-Type 2 Asthma: Similarities, Differences, and Challenges. [PDF]

J Inflamm Res
Maglio A, D'Auria LO, Franzese A, Liguori ME, Gramazio S, Arnone G, Longobardi V, Pelaia C, Pelaia G, Calabrese C, Vitale C, Vatrella A.   +11 more
europepmc   +1 more source

Efficacy of Biologics in Patients with Moderate to Very Severe COPD: A Systematic Review. [PDF]

Int J Chron Obstruct Pulmon Dis
Brightling CE, Rabe KF, Singh D, Han MK, Bhutani M, Bourbeau J, Nair P, Drummond MB, Gandhi EA, Sindhwani NS, Molfino NA, Parulekar AD, Ponnarambil SS.   +12 more
europepmc   +1 more source

Tezepelumab in patients with asthma: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Clinics (Sao Paulo)
Shang W, Wang G, Han D.
europepmc   +1 more source

Efficacy and Safety of Biologic Therapies for Uncontrolled Asthma: An Overview of Systematic Reviews. [PDF]

Pediatr Pulmonol
Faria RJ, Bazoni PS, Santos JBRD, Silva ETD, Silva MRRD.   +4 more
europepmc   +1 more source

Characteristics and clinical outcomes of patients with severe asthma receiving tezepelumab after marketing approval in Spain (T-ROSS II study): an observational study protocol. [PDF]

BMJ Open
Domingo C, Monteagudo G, Ramos-Lima F, Alegría M, Niza G, Robles M, Domínguez-Ortega J.   +6 more
europepmc   +1 more source

Improvements in small airway dysfunction and respiratory symptoms following tezepelumab for severe asthma. [PDF]

ERJ Open Res
Kupershmidt A, Elkayam G, Urtreger N, Malloul A, Regev-Friedman I, Unterman A, Amor SM, Enghelberg S, Freund O, Bar-Shai A.   +9 more
europepmc   +1 more source